Jiangsu Yangtze River Pharmaceutical Group Company Ltd., commonly referred to as Yangtze River Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in Jiangsu, China. Established in 1994, the company has grown to become a leading manufacturer and supplier of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong focus on research and development, Yangtze River Pharmaceutical has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. The company is renowned for its commitment to quality and innovation, offering unique products that cater to various therapeutic areas. As a key contributor to the global pharmaceutical landscape, Yangtze River Pharmaceutical continues to expand its operational reach, solidifying its reputation as a trusted name in healthcare solutions.
How does Jiangsu Yangtze River Pharmaceutical Group Company Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Jiangsu Yangtze River Pharmaceutical Group Company Ltd.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jiangsu Yangtze River Pharmaceutical Group Company Ltd., headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of publicly available information suggests that Jiangsu Yangtze River Pharmaceutical Group may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the pharmaceutical industry increasingly prioritises sustainability, it remains essential for companies like Jiangsu Yangtze River to develop and communicate their climate strategies to align with global environmental standards.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jiangsu Yangtze River Pharmaceutical Group Company Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.